With the completion of more than 550 studies covering a broad range of therapeutic areas by our clinical operation departments ZEINCRO offers a portfolio of proven experience.

ZEINCRO has an extensive experience in managing Phase I-IV as well as large post marketing non-interventional studies in cardiology, oncology, CNS, metabolic diseases & endocrinology and heamatology which represent the majority of the pharmaceutical/biotechnology product pipeline.

data derived from studies completed by December 2016